{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:25:16Z","timestamp":1778606716789,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12098-019-03098-w","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T16:23:58Z","timestamp":1576167838000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nitazoxanide in the Treatment of Intestinal Parasitic Infections in Children: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"87","author":[{"given":"Jinyi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0529-0417","authenticated-orcid":false,"given":"Xue","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"3098_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1590\/0037-8682-0128-2015","volume":"49","author":"AQ Goncalves","year":"2016","unstructured":"Goncalves AQ, Junqueira ACV, Abellana R, et al. Prevalence of intestinal parasites and risk factors for specific and multiple helminth infections in a remote city of the Brazilian Amazon. Rev Soc Bras Med Trop. 2016;49:119\u201324.","journal-title":"Rev Soc Bras Med Trop"},{"key":"3098_CR2","doi-asserted-by":"crossref","unstructured":"Muller I, Yap P, Steinmann P, et al. Intestinal parasites, growth and physical fitness of schoolchildren in poor neighbourhoods of Port Elizabeth, South Africa: a cross-sectional survey. Parasit Vectors. 2016;9:488.","DOI":"10.1186\/s13071-016-1761-5"},{"key":"3098_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jiph.2012.11.004","volume":"6","author":"M Shobha","year":"2013","unstructured":"Shobha M, Bithika D, Bhavesh S. The prevalence of intestinal parasitic infections in the urban slums of a city in Western India. J Infect Public Health. 2013;6:142\u20139.","journal-title":"J Infect Public Health"},{"key":"3098_CR4","unstructured":"Kaur R, Rawat D, Kakkar M, Uppal B, Sharma VK. Intestinal parasites in children with diarrhea in Delhi, India. Southeast Asian J Trop Med Public Health. 2002;33:725\u20139."},{"key":"3098_CR5","unstructured":"World Health Organization. Soil-Transmitted Helminth Infections. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/soil-transmitted-helminth-infections. Accessed 14th March 2019."},{"key":"3098_CR6","unstructured":"Xu LQ. [A national survey on current status of the important parasitic diseases in human population]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005;23:332\u201340 (in Chinese)."},{"key":"3098_CR7","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/S0140-6736(09)60233-6","volume":"373","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 2009;373:1570\u20135.","journal-title":"Lancet."},{"key":"3098_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","volume":"382","author":"KL Kotloff","year":"2013","unstructured":"Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study. Lancet. 2013;382:209\u201322.","journal-title":"Lancet."},{"key":"3098_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003042","volume":"8","author":"R Sarkar","year":"2014","unstructured":"Sarkar R, Tate JE, Ajjampur SSR, et al. Burden of diarrhea, hospitalization and mortality due to cryptosporidial infections in Indian children. PLoS Negl Trop Dis. 2014;8:e3042.","journal-title":"PLoS Negl Trop Dis"},{"key":"3098_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(03)12830-9","volume":"361","author":"SJ Stanley","year":"2003","unstructured":"Stanley SJ. Amoebiasis. Lancet. 2003;361:1025\u201334.","journal-title":"Lancet."},{"key":"3098_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1179\/2047773212Y.0000000019","volume":"106","author":"F Ortiz-Castillo","year":"2012","unstructured":"Ortiz-Castillo F, Salinas-Aragon LE, Sanchez-Aguilar M, et al. Amoebic toxic colitis: analysis of factors related to mortality. Pathog Glob Health. 2012;106:245\u20138.","journal-title":"Pathog Glob Health"},{"key":"3098_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13071-017-2111-y","volume":"10","author":"SA Squire","year":"2017","unstructured":"Squire SA, Ryan U. Cryptosporidium and Giardia in Africa: current and future challenges. Parasit Vectors. 2017;10:195.","journal-title":"Parasit Vectors"},{"key":"3098_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1128\/CMR.17.4.1012-1030.2004","volume":"17","author":"G Borkow","year":"2004","unstructured":"Borkow G, Bentwich Z. Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev. 2004;17:1012\u201330.","journal-title":"Clin Microbiol Rev"},{"key":"3098_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1995-7645(11)60168-5","volume":"4","author":"A Alemu","year":"2011","unstructured":"Alemu A, Shiferaw Y, Getnet G, Yalew A, Addis Z. Opportunistic and other intestinal parasites among HIV\/AIDS patients attending Gambi higher clinic in Bahir Dar city, north West Ethiopia. Asian Pac J Trop Med. 2011;4:661\u20135.","journal-title":"Asian Pac J Trop Med"},{"key":"3098_CR15","doi-asserted-by":"publisher","first-page":"971958","DOI":"10.1155\/2012\/971958","volume":"2012","author":"AK Jha","year":"2012","unstructured":"Jha AK, Uppal B, Chadha S, et al. Clinical and microbiological profile of HIV\/AIDS cases with diarrhea in north India. J Pathog. 2012;2012:971958.","journal-title":"J Pathog"},{"key":"3098_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","volume":"384","author":"CJ Murray","year":"2014","unstructured":"Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:1005\u201370.","journal-title":"Lancet."},{"key":"3098_CR17","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2165\/00003495-200767130-00015","volume":"67","author":"VR Anderson","year":"2007","unstructured":"Anderson VR, Curran MP. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs. 2007;67:1947\u201367.","journal-title":"Drugs."},{"key":"3098_CR18","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1086\/320751","volume":"32","author":"P Abboud","year":"2001","unstructured":"Abboud P, Lem\u00e9e V, Gargala G, et al. Successful treatment of metronidazole-and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 2001;32:1792\u20134.","journal-title":"Clin Infect Dis"},{"key":"3098_CR19","first-page":"122","volume":"64","author":"R Rodriguez-Garcia","year":"1999","unstructured":"Rodriguez-Garcia R, Rodriguez-Guzman LM, Cruz DCA. Effectiveness and safety of mebendazole compared to nitazoxanide in the treatment of Giardia lamblia in children. Rev Gastroenterol Mex. 1999;64:122\u20136.","journal-title":"Rev Gastroenterol Mex"},{"key":"3098_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1046\/j.1365-2036.2001.01066.x","volume":"15","author":"JJ Ortiz","year":"2001","unstructured":"Ortiz JJ, Ayoub A, Gargala G, Lopez-Chegne N, Favennec L. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from northern Peru. Aliment Pharmacol Ther. 2001;15:1409\u201315.","journal-title":"Aliment Pharmacol Ther"},{"key":"3098_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1086\/321008","volume":"184","author":"JF Rossignol","year":"2001","unstructured":"Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001;184:103\u20136.","journal-title":"J Infect Dis"},{"key":"3098_CR22","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","volume":"360","author":"B Amadi","year":"2002","unstructured":"Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002;360:1375\u201380.","journal-title":"Lancet."},{"key":"3098_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4269\/ajtmh.2002.66.251","volume":"66","author":"CE Davila-Gutierrez","year":"2002","unstructured":"Davila-Gutierrez CE, Vasquez C, Trujillo-Hernandez B, Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg. 2002;66:251\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"3098_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0035-9203(02)90301-9","volume":"96","author":"JJ Ortiz","year":"2002","unstructured":"Ortiz JJ, Lopez-Chegne N, Gargala G, Favennec L. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans R Soc Trop Med Hyg. 2002;96:193\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3098_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1046\/j.1365-2036.2003.01419.x","volume":"17","author":"L Favennec","year":"2003","unstructured":"Favennec L, Ortiz JJ, Gargala G, et al. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther. 2003;17:265\u201370.","journal-title":"Aliment Pharmacol Ther"},{"key":"3098_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1590\/S0036-36342004000400008","volume":"46","author":"U Belkind-Valdovinos","year":"2004","unstructured":"Belkind-Valdovinos U, Belkind-Gerson J, Sanchez-Francia D, Espinoza-Ruiz MM, Lazcano-Ponce E. Nitazoxanide vs albendazole against intestinal parasites in a single dose and for three days. Salud Publica Mex. 2004;46:333\u201340.","journal-title":"Salud Publica Mex"},{"key":"3098_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1542-3565(05)00427-1","volume":"3","author":"JF Rossignol","year":"2005","unstructured":"Rossignol JF, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol. 2005;3:987\u201391.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3098_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.trstmh.2007.04.001","volume":"101","author":"JF Rossignol","year":"2007","unstructured":"Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg. 2007;101:1025\u201331.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3098_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1179\/136485908X267894","volume":"102","author":"AA Escobedo","year":"2008","unstructured":"Escobedo AA, Alvarez G, Gonzalez ME, et al. The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Ann Trop Med Parasitol. 2008;102:199\u2013207.","journal-title":"Ann Trop Med Parasitol"},{"key":"3098_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2334-9-195","volume":"9","author":"B Amadi","year":"2009","unstructured":"Amadi B, Mwiya M, Sianongo S, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009;9:195.","journal-title":"BMC Infect Dis"},{"key":"3098_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001685","volume":"6","author":"B Speich","year":"2012","unstructured":"Speich B, Ame SM, Ali SM, et al. Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial. PLoS Negl Trop Dis. 2012;6:e1685.","journal-title":"PLoS Negl Trop Dis"},{"key":"3098_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.12816\/0006403","volume":"43","author":"SM Hussien","year":"2013","unstructured":"Hussien SM, Abdella OH, Abu-Hashim AH, et al. Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children. J Egypt Soc Parasitol. 2013;43:463\u201370.","journal-title":"J Egypt Soc Parasitol"},{"issue":"6","key":"3098_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0035-9203(97)90531-9","volume":"91","author":"Ra\u00fal Romero Cabello","year":"1997","unstructured":"Cabello RR, Guerrero LR, Garcia MRM, Cruz AG. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg. 1997;91:701\u20133.","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"3098_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jaad.2009.06.044","volume":"64","author":"J Gurgen","year":"2011","unstructured":"Gurgen J, Hogan D, Grace E, Johnson D. Nitazoxanide in the treatment of chronic cutaneous leishmaniasis resistant to traditional sodium stibogluconate. J Am Acad Dermatol. 2011;64:202\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"3098_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2125.2007.02873.x","volume":"63","author":"I Abubakar","year":"2007","unstructured":"Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol. 2007;63:387\u201393.","journal-title":"Br J Clin Pharmacol"},{"key":"3098_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4269\/ajtmh.1997.56.637","volume":"56","author":"O Doumbo","year":"1997","unstructured":"Doumbo O, Rossignol JF, Pichard E, et al. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am J Trop Med Hyg. 1997;56:637\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"3098_CR37","first-page":"147","volume":"2","author":"MA Rodriguez-Perez","year":"2011","unstructured":"Rodriguez-Perez MA, Perez-Vega JA, Cen-Aguilar JF, Rodr\u00edguez-Canul R. Lessons from a study in a rural community from southern Mexico: risk factors associated to transmission and reinfection of gastrointestinal parasites after albendazole treatment. Res Rep Trop Med. 2011;2:147\u201353.","journal-title":"Res Rep Trop Med"},{"key":"3098_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.trstmh.2011.11.007","volume":"106","author":"JF Rossignol","year":"2012","unstructured":"Rossignol JF, Lopez-Chegne N, Julcamoro LM, Carrion ME, Bardin MC. Nitazoxanide for the empiric treatment of pediatric infectious diarrhea. Trans R Soc Trop Med Hyg. 2012;106:167\u201373.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3098_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019632","volume":"8","author":"CS Waddington","year":"2018","unstructured":"Waddington CS, McLeod C, Morris P, et al. The NICE-GUT trial protocol: a randomised, placebo-controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian aboriginal children. BMJ Open. 2018;8:e019632.","journal-title":"BMJ Open"},{"key":"3098_CR40","first-page":"11","volume":"56","author":"H Bojar","year":"2010","unstructured":"Bojar H, Knap JP. Nitazoxanide (\"Alinia\")- a promising antiparasitic drug. Wiad Parazytol. 2010;56:11\u20138.","journal-title":"Wiad Parazytol"},{"key":"3098_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5414\/CPP40221","volume":"40","author":"A Stockis","year":"2002","unstructured":"Stockis A, De Bruyn S, Gengler C, Rosillon D. Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d. Int J Clin Pharmacol Ther. 2002;40:221\u20137.","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-03098-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-019-03098-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-03098-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T01:15:26Z","timestamp":1607649326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-019-03098-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3098"],"URL":"https:\/\/doi.org\/10.1007\/s12098-019-03098-w","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"6 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}